PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, United States.\', \'Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.\', \'Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.\', \'Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States.\', \'Mary H. Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, MI, United States.\', \'Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.\', \'Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States.\', \'Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.\', \'Medicine Service, VA Ann Arbor Healthcare System, Ann Arbor, MI, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.729189
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34603303
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all